Sectral Articles
Stock Commentary - New York - week to Oct 1, 2007
8 October 2007
Sanofi and Chugai to end marketing deal
6 August 2007
Mylan Lab; acebutolol hydrochloride
8 May 1995
EXTENSION TO JAPANESE FORMULARY
11 October 1993
DRUG THERAPY FOR MILD HYPERTENSION FAVORED
16 August 1993
AMERICAN HOME HAS CONFIDENCE FOR 1993
12 April 1993
Showing 1-6 of 6 articles
- 1
- Bristol-Myers' data on Yervoy and nivolumab causes a stir
- Boehringer Ingelheim transitions to propellant-free Combivent Respimat; names new BMD member
- Encouraging results with Sangamo's SB-728-T in HIV treatment
- New study shows UCB's Neupro reduces NSBP in RLS patient
- Sanofi prepares for regulatory filing of MF candidate on positive JAKARTA study results
